iNEXT-Discovery aims to enable access to structural biology research infrastructures for all European researchers, and especially also for non-experts in structural biology. For that reason it brings together a diversity of large research facilities and other groups in a single consortium. Funded by the European Commission Horizon-2020 framework program from February 2020 for a period of four years, iNEXT-Discovery is built on three pillars:
We encourage all researchers from academic and industry to use our high-end structural biology facilities in Europe, to perform the translational research relevant for the sectors of health (e.g. drug discovery, target validation), biotechnology (e.g. new enzymes), biomaterials, and food science. Please have a look and don't hesitate to contact us with your questions! |